Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 22 Carcinoma, Hepatocellular 15 Small Cell Lung Carcinoma 11 Triple Negative Breast Neoplasms 9 Neoplasms 8 Colorectal Neoplasms 6 Breast Neoplasms 6 Urinary Bladder Neoplasms 5 Lung Neoplasms 5 Carcinoma, Renal Cell 5 Ovarian Neoplasms 4 Carcinoma, Transitional Cell 3 Carcinoma 3 Uterine Cervical Neoplasms 2 Prostatic Neoplasms 2 Melanoma 2 Colonic Neoplasms 2 Venous Thrombosis 1 Urologic Neoplasms 1 Stomach Neoplasms 1 Squamous Non-Small Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Diseases 1 Rectal Neoplasms 1 Radiation Pneumonitis 1 Prostatic Neoplasms, Castration-Resistant 1 Peritoneal Neoplasms 1 Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer 1 Non-Squamous Non-Small Cell Lung Cancer 1 Non-Small-Cell Lung 1

Interventions

Radiosurgery 23 Radiotherapy 20 Temozolomide 17 Lomustine 9 Bevacizumab 8 Surgical Procedures, Operative 7 Procarbazine 6 Vincristine 5 Nivolumab 5 Memantine 5 Magnetic Resonance Spectroscopy 4 Filgrastim 4 Etoposide 4 Cisplatin 4 Carboplatin 4 Specimen Handling 3 Sodium Chloride 3 Radiation 3 Methylphenidate 3 Mental Status and Dementia Tests 3 Granulocyte Colony-Stimulating Factor 3 Gefitinib 3 Cyclophosphamide 3 Corticotropin-Releasing Hormone 3 Carmustine 3 icotinib 2 etoposide phosphate 2 efaproxiral 2 X-Rays 2 Tranexamic Acid 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Brain Neoplasms × atezolizumab × Clear all

NCT05317858 2026-04-16

LIMITLESS

InSightec

Phase 3 Recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡